Mylan (MYL) is No Generic When it Comes to Growth Potential - Barron's

Go back to Mylan (MYL) is No Generic When it Comes to Growth Potential - Barron's
Momenta Phamaceuticals, Inc. (NASDAQ: MNTA) Delayed: 52.48 --0 (-0%)
Previous Close $52.48    52 Week High $18.32 
Open $39.17    52 Week Low $7.86 
Day High $52.48    P/E N/A 
Day Low $52.48    EPS $-2.13 
Volume 147,551       

Mylan Inc. (NASDAQ: MYL) Delayed: 15.86 --0 (-0%)
Previous Close $15.86    52 Week High $55.51 
Open $10.56    52 Week Low $33.60 
Day High $15.86    P/E 10.43 
Day Low $15.86    EPS $1.52 
Volume 45,581       

NOVARTIS AG (NYSE: NVS) Delayed: 160.31 --0 (-0%)
Previous Close $160.31    52 Week High $89.15 
Open $160.31    52 Week Low $69.84 
Day High $160.31    P/E N/A 
Day Low $160.31    EPS $0.00 
Volume 284       

SANOFI (NASDAQ: SNY) Delayed: 45.83 --0 (-0%)
Previous Close $45.83    52 Week High $44.76 
Open $45.83    52 Week Low $36.81 
Day High $45.83    P/E N/A 
Day Low $45.83    EPS $0.00 
Volume 3,154       

TEVA PHARMACEUTICAL INDUSTRIES (NYSE: TEVA) Delayed: 37.47 --0 (-0%)
Previous Close $37.47    52 Week High $66.55 
Open $37.47    52 Week Low $37.82 
Day High $37.47    P/E N/A 
Day Low $37.47    EPS $0.00 
Volume 3,046